About IMP/Med-E-Cell
Technology and products offered by Insect Management Products (IMP) are the result of years of research and development by Med-E-Cell in the field of fluid delivery, based exclusively on Med-E-Cell’s patented electrochemical gas generation technology platform.
Med-E-Cell’s business model is to pioneer the development of new products and to out-license/sell IP rights for specific applications and markets. In this business model, Med-E-Cell does not compete with its licensees.
Consequently, IMP is a provider of technology/products to research and industrial organizations involved in the management and control of insects. Research organizations, distributors and providers of insect management systems are encouraged to inquire about IMP’s technology, products and licensing opportunities.
A patent portfolio in excess of 30 U.S. patents protects the Prime Mover™ technology platform, which has been successfully applied to a variety of prototypes and products in the field of:
- medical drug delivery
- wound treatment
- veterinary therapeutics
- preclinical investigations
- pheromone releasers
- carbon dioxide source for mosquito attractants
- drug stabilization through oxygen removal
- fragrance releasers
For additional information about Med-E-Cell, please refer to http://www.medecell.com.
